Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis

International Journal of Cancer

Volumn 93, Issue 4, 2001, Pages 475-480

  Usuda, Jitsuo ^a,d   Okunaka, Tetsuya ^a   Furukawa, Kinya ^a   Tsuchida, Takaaki ^a   Kuroiwa, Yukari ^a   Ohe, Yuichiro ^b   Saijo, Nagahiro ^b   Nishio, Kazuto ^c   Konaka, Chimori ^a   Kato, Harubumi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; IL 6; PDT

Indexed keywords

CYTOCHROME C; DNA FRAGMENT; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; PHOTOSENSITIZING AGENT; PROTEIN BAX; PROTEIN BCL 2; TALAPORFIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL NUCLEUS; CYTOKINE PRODUCTION; CYTOTOXICITY; DIODE LASER; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, LEWIS LUNG; GENE EXPRESSION; GENE THERAPY; INTERLEUKIN-6; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035882574     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1374     Document Type: Article

References (21)

1. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light
2. A prospective phase II study on photodynamic therapy with Photofrin II for centrally located early stage lung cancer
3. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy
4. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor
5. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo
6. Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat
7. Interleukin-6 cDNA transfected lewis lung carcinoma cells show unaltered net tumor growth rate but cause weight loss and shorten survival in syngenic mice
8. Combination effect of vaccination with IL-2 and IL-4 cDNA transfected cells on the induction of a therapeutic immune response against lewis lung carcinoma cells
9. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNA co-transfected subline
10. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
11. The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy
12. Determinants of the apoptotic response to lysosomal photo damage
13. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-κB DNA binding
14. The photobiology of photodynamic therapy: Cellular targets and mechanisms
15. Promotion of photodynamic therapy-induced apoptosis by stress kinases
16. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone
17. Both stat3-activation and stat 3-independent bcl-2 downregulation are important for interleukin-6-induced apoptosis of 1A9-M cells
18. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function
19. p53 regulate mitochondrial potential through reactive oxygen species and induces cytochrome C-independent apoptosis blocked by bcl-2
20. An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis
21. Growth factors prevent changes in bcl-2 and bax expression and neuronal apoptosis induced by nitric oxide